Issues related to reimbursement under Medicare Part B and Part D; Most Favored Nation (MFN).
2025 · 4th Quarter (Oct 1 - Dec 31)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Filed by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 4th Quarter - Report
- Posted
- Jan 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)
- Filing UUID
- 0f244eb4-2f6f-449c-8130-ac4105cee549
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to drug pricing, generally; 340B Drug Pricing Program; pharmacy benefit managers; drug patents and patent reporting requirements; H.R. 1262/S. 932, Give Kids a Chance Act.
BIOSECURE Act/S. Amdt. 3236 to S. 2296, the National Defense Authorization Act for FY2026.
Literal federal measure citations: S. 2296
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.